Cell Biotech Co., Ltd. (KOSDAQ:049960)

Elevation Oncology Ratios and Metrics

Market cap in millions KRW. Fiscal year is January - December.

Fiscal Year	Current	FY 2024	FY 2023	FY 2022	FY 2021	FY 2020
Period Ending	Aug 6, 2025	Dec 31, 2024	Dec 31, 2023	Dec 31, 2022	Dec 31, 2021	Dec 31, 2020
Market Capitalization	89,929	97,662	76,789	86,918	133,300	166,285
Market Cap Growth	5.18%	27.18%	-11.65%	-34.80%	-19.84%	21.02%
Enterprise Value	1,497	19,190	10,612	22,959	70,193	110,107
Last Close Price	13140.00	14270.00	10865.68	11807.86	16926.10	20593.71
PE Ratio	6.45	6.46	12.18	10.50	12.84	52.14
Forward PE	-	8.16	8.16	8.16	8.16	8.16
PS Ratio	1.87	1.96	1.43	1.72	2.84	3.65
PB Ratio	0.73	0.79	0.69	0.80	1.25	1.66
P/TBV Ratio	0.74	0.80	0.70	0.82	1.27	1.69
P/FCF Ratio	5.44	5.38	12.26	8.32	9.49	25.64
P/OCF Ratio	5.12	5.07	9.82	6.78	8.95	17.39
EV/Sales Ratio	0.03	0.38	0.20	0.45	1.50	2.42
EV/EBITDA Ratio	0.14	1.80	1.74	2.37	6.36	14.98
EV/EBIT Ratio	0.21	2.82	4.83	3.79	9.67	30.03
EV/FCF Ratio	0.09	1.06	1.69	2.20	5.00	16.98
Debt / Equity Ratio	0.01	0.01	0.01	0.01	0.01	0.01
Debt / EBITDA Ratio	0.08	0.10	0.25	0.10	0.07	0.18
Debt / FCF Ratio	0.05	0.06	0.25	0.09	0.06	0.21
Asset Turnover	0.38	0.40	0.46	0.44	0.43	0.43
Inventory Turnover	3.03	3.39	3.68	3.34	3.21	3.44
Quick Ratio	10.48	15.71	15.74	9.54	10.89	12.96
Current Ratio	11.08	16.57	16.99	10.24	11.71	14.02
Return on Equity (ROE)	11.85%	12.82%	5.73%	7.71%	10.05%	3.13%
Return on Assets (ROA)	3.50%	3.43%	1.18%	3.31%	4.16%	2.15%
Return on Capital (ROIC)	3.73%	3.56%	1.23%	3.49%	4.34%	2.23%
Return on Capital Employed (ROCE)	5.70%	5.50%	1.90%	5.60%	6.80%	3.60%
Earnings Yield	15.50%	15.49%	8.21%	9.53%	7.79%	1.92%
FCF Yield	18.37%	18.57%	8.16%	12.02%	10.54%	3.90%
Dividend Yield	3.42%	3.15%	4.14%	3.81%	2.66%	2.19%
Payout Ratio	22.10%	20.36%	48.86%	38.43%	30.65%	136.11%
Buyback Yield / Dilution	-	-	0.73%	2.50%	0.32%	4.25%
Total Shareholder Return	3.40%	3.15%	4.88%	6.31%	2.98%	6.44%

Updated Nov 14, 2024. Source: S&P Global Market Intelligence. Standard template. Financial Sources.